Model for paraaortic lymph node metastasis produced by orthotopic implantation of ovarian carcinoma cells in athymic nude mice

European Journal of Cancer

Volumn 40, Issue 1, 2004, Pages 158-163

  Tamada, Y ^a,b   Aoki, D ^a   Nozawa, S ^a   Irimura, T ^b  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Animal model; Lymph node metastasis; Ovarian cancer

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CANCER STAGING; CANCER THERAPY; CARCINOMA CELL; CELL CULTURE; CELL LINE; CELL SELECTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE METASTASIS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; OVARY CARCINOMA; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL;

EID: 0347627359     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.08.008     Document Type: Article

References (36)

1. Sakuragi N., Yamada H., Oikawa M.et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol. Oncol. 79:2000;251-255.
2. Onda T., Yoshikawa H., Yokota H., Yasugi T., Taketani Y. Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer. 78:1996;803-808.
3. Petru E., Lahousen M., Tamussino K.et al. Lymphadenectomy in stage I ovarian cancer. Am. J. Obstet. Gynecol. 170:1994;656-662.
4. Hanson M.B., van Nagell J.R. Jr., Powell D.E.et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer. 55:1985;1753-1757.
5. Hashii K., Tohya K., Kimura M.et al. Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells. Invasion Metastasis. 17:1997;149-157.
6. Yamaura T., Doki Y., Murakami K., Saiki I. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice. Hum. Cell. 12:1999;197-204.
7. Yamaura T., Murakami K., Doki Y.et al. Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer. Neoplasia. 2:2000;315-324.
8. Qian F., Vaux D.L., Weissman I.L. Expression of the integrin α4 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell. 77:1994;335-374.
9. Kikuchi Y., Hirata J., Kita T., Imaizumi E., Tode T., Nagata I. Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells. Gynecol. Oncol. 49:1993;365-372.
10. Hirata J., Kikuchi Y., Kita T.et al. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O- tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine. Int. J. Cancer. 55:1993;521-527.
11. Kudoh K., Kikuchi Y., Hiramatsu H.et al. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin. Eur. J. Cancer. 33:1997;122-128.
12. Hiramatsu H., Kikuchi Y., Kudoh K., Kita T., Tode T., Nagata I. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine- HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice. Jpn. J. Cancer Res. 88:1997;1003-1008.
13. Kikuchi Y., Hirata J., Yamamoto K.et al. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells. Jpn. J. Cancer Res. 88:1997;213-217.
14. Kikuchi Y., Hirata J., Hisano A., Tode T., Kita T., Nagata I. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II). Gynecol. Oncol. 58:1995;11-15.
15. Fidler I.J. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev. 5:1986;29-49.
16. Mclemore T.L., Egglestone L.C., Shoemaker R.H.et al. Comparison of intrapulmonary, percutaneous, intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res. 48:1988;2880-2886.
17. Mclemore T.L., Liu M.C., Blacker P.C.et al. Novel intrapulmonary model for orthotopic progression of human lung cancers in athymic nude mice. Cancer Res. 47:1987;5132-5140.
18. Morikawa K., Walker S.M., Jessup J.M., Fidler I.J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinoma implanted into nude mice. Cancer Res. 48:1988;6863-6871.
19. Naito S., von Eshenbach A.C., Giavazzi R., Fidler I.J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 46:1986;4109-4115.
20. Tan M.H., Chu T.M. Characterization of the tumorigenic and metastasis properties of a human pancreatic tumor cell line (ASPC-1) implanted ortho-topically into nude mice. Tumor Biol. 6:1985;89-98.
21. Kiguchi K., Kubota T., Aoki D.et al. A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer. Clin. Exp. Metastasis. 16:1998;751-756.
22. Tezuka Y., Yonezawa S., Maruyama I.et al. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res. 55:1995;4196-4200.
23. Guo X., Friess H., Graber H.U.et al. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 56:1996;4876-4880.
24. Schmalfeldt B., Kuhn W., Reuning U.et al. Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. Cancer Res. 55:1995;3958-3963.
25. Kaufmann M., Heider K.H., Sinn H.P., von Minckwitz G., Ponta H., Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 345:1995;615-619.
26. Tiwari R.K., Borgen P.I., Wong G.Y., Cordon-Cardo C., Osborne M.P. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res. 12:1992;419-425.
27. Wang C., Thor A.D., Moore 2nd D.H.et al. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res. 4:1998;567-576.
28. Ueno H., Nakamura H., Inoue M.et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57:1997;2055-2060.
29. Adachi Y., Itoh F., Yamamoto H.et al. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int. J. Oncol. 13:1998;1031-1035.
30. Yamashita K., Azumano I., Mai M., Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (Matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int. J. Cancer (Pred. Oncol.). 79:1998;187-194.
31. Yamamoto H., Itoh F., Fukushima H., Hinoda Y., Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int. J. Cancer (Pred. Oncol.). 84:1999;400-403.
32. Volm M., van Kaick G., Mattern J. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clin. Exp. Metastasis. 12:1994;329-334.
33. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 45:1999;252-258.
34. Head J.R., Seeling L.L. Jr. Lymphatic vessels in the uterine endometrium of virgin rats. J. Reprod. Immunol. 6:1984;157-166.
35. Burghardt E., Winter R. The effect of chemotherapy on lymph node metastases in ovarian cancer. Bailliere's Clin. Obstet. Gynaecol. 3:1989;167-171.
36. Tulusan A.H., Adam R., Reinhardt M.et al. Lymph node metastasis in epithelial ovarian cancer. Sharp F., Mason W.P., Leake R.E. Ovarian Cancer: Biological and Therapeutic Challenges. 1990;443-445 Chapman & Hall, London.